Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo Network Comparison Type description Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2551 to 2600 of 8289 in total
Network Comparison Type: Divided
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1276\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b. [source:refseq;acc:nm\_175055]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.194\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02248\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CHRNA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.231\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
167.177\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02425\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1277\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.s (h2b/s). [source:swissprot;acc:p57053]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.194\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02248\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SPHK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.231\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
167.177\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02425\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1278\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.e (h2b/e). [source:swissprot;acc:q99879]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.194\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02248\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SESN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sestrin 3. [source:swissprot;acc:p58005]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.219\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02415\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1279\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.336\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02248\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SESN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sestrin 2 (hi95). [source:swissprot;acc:p58004]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.219\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02415\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1280\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4A11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4a11 precursor (ec 1.14.15.3) (cypiva11) (fatty acid omega-hydroxylase) (p-450 hk omega) (lauric acid omega-hydroxylase) (cyp4aii) (p450-hl-omega). [source:swissprot;acc:q02928]\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
HIST1H2BL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.c (h2b/c). [source:swissprot;acc:q99880]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.196\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02247\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1281\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone h2b.d (h2b/d). [source:swissprot;acc:q99877]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
203.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.195\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f3 (ec 1.14.13.30) (cypivf3) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:q08477]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1282\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTGF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
connective tissue growth factor precursor (hypertrophic chondrocyte- specific protein 24). [source:swissprot;acc:p29279]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.383\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.805\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02246\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f8 (ec 1.14.14.1) (cypivf8). [source:swissprot;acc:p98187]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1283\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.134\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.628\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02246\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4X1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
likely ortholog of rat cytochrome p450 4x1. [source:refseq;acc:nm\_178033]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1284\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f12 (ec 1.14.14.1) (cypivf12). [source:swissprot;acc:q9hcs2]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
FAH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fumarylacetoacetase (ec 3.7.1.2) (fumarylacetoacetate hydrolase) (beta-diketonase) (faa). [source:swissprot;acc:p16930]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.294\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.852\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02245\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1285\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f2 (ec 1.14.13.30) (cypivf2) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:p78329]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PHB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
prohibitin. [source:swissprot;acc:p35232]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
186.195\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
182.109\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02244\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1286\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4F11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4f11 (ec 1.14.14.1) (cypivf11). [source:swissprot;acc:q9hbi6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
GNL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.355\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02244\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1287\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACSL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
long-chain-fatty-acid--coa ligase 3 (ec 6.2.1.3) (long-chain acyl-coa synthetase 3) (lacs 3). [source:swissprot;acc:o95573]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
201.127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.714\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02243\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4A22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj18d14.4 (cytochrome p450, subfamily iva, polypeptide 11). [source:sptrembl;acc:q9ntl5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1288\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
C21orf66\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gc-rich sequence dna-binding factor homolog. [source:swissprot;acc:q9y5b6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.236\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.757\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02242\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CYP4B1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 4b1 (ec 1.14.14.1) (cypivb1) (p450-hp). [source:swissprot;acc:p13584]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1289\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
FLOT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
flotillin-1. [source:swissprot;acc:o75955]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
GLI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein gli2 (tax helper protein). [source:swissprot;acc:p10070]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.619\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02242\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1290\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP1R12B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 12b isoform a; myosin phosphatase regulatory subunit; myosin phosphatase, target subunit 2. [source:refseq;acc:nm\_002481]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
195.789\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
191.498\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02241\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SESN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sestrin 1 (p53-regulated protein pa26). [source:swissprot;acc:q9y6p5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02414\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1291\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACSL4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
long-chain-fatty-acid--coa ligase 4 (ec 6.2.1.3) (long-chain acyl-coa synthetase 4) (lacs 4). [source:swissprot;acc:o60488]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.117\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.709\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02241\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
HAS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hyaluronan synthase 2 (ec 2.4.1.212) (hyaluronate synthase 2) (hyaluronic acid synthase 2) (ha synthase 2). [source:swissprot;acc:q92819]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.093\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.399\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.024\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1292\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CASP7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
caspase-7 precursor (ec 3.4.22.-) (ice-like apoptotic protease 3) (ice-lap3) (apoptotic protease mch-3) (cmh-1). [source:swissprot;acc:p55210]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
233.942\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.46\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
NONO\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
54 kda nuclear rna- and dna-binding protein (p54(nrb)) (p54nrb) (55 kda nuclear protein) (nmt55) (non-pou domain-containing octamer- binding protein) (dna-binding p52/p100 complex, 52 kda subunit). [source:swissprot;acc:q15233]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.544\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.152\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02239\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1293\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CASP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
apopain precursor (ec 3.4.22.-) (cysteine protease cpp32) (yama protein) (cpp-32) (caspase-3) (casp-3) (srebp cleavage activity 1) (sca-1). [source:swissprot;acc:p42574]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.942\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.46\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.024\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PSPC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
paraspeckle protein 1. [source:refseq;acc:nm\_018282]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.543\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.152\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02239\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1294\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HAS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hyaluronan synthase 1 (ec 2.4.1.212) (hyaluronate synthase 1) (hyaluronic acid synthase 1) (ha synthase 1) (huhas1). [source:swissprot;acc:q92839]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.093\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.399\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.024\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SEC31A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.144\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.676\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02238\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1295\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HAS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hyaluronan synthase 3 (ec 2.4.1.212) (hyaluronate synthase 3) (hyaluronic acid synthase 3) (ha synthase 3). [source:swissprot;acc:o00219]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.093\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
226.399\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.024\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC3A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neutral and basic amino acid transport protein rbat (b(0,+)-type amino acid transport protein) (nbat) (d2h). [source:swissprot;acc:q07837]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.695\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.323\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02238\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1296\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEC31B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
204.174\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.705\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC37A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol-3-phosphate transporter (g-3-p transporter) (g-3-p permease). [source:swissprot;acc:p57057]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.062\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.174\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02394\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1297\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAPK11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitogen-activated protein kinase 12 (ec 2.7.1.37) (extracellular signal-regulated kinase 6) (erk-6) (erk5) (stress-activated protein kinase-3) (mitogen-activated protein kinase p38 gamma) (map kinase p38 gamma). [source:swissprot;acc:p53778]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.193\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.812\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02237\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PRODH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proline oxidase, mitochondrial precursor (ec 1.5.3.-) (proline dehydrogenase). [source:swissprot;acc:o43272]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.062\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
204.174\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02394\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1298\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.12) (e2) (pdc-e2) (70 kda mitochondrial autoantigen of primary biliary cirrhosis) (pbc) (m2 antigen complex 70 kda subunit). [source:swissprot;acc:p10515]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
206.482\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
211.404\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02384\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
GLI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein gli1 (glioma-associated oncogene) (oncogene gli). [source:swissprot;acc:p08151]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.074\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.63\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02237\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1299\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aconitate hydratase, mitochondrial precursor (ec 4.2.1.3) (citrate hydro-lyase) (aconitase). [source:swissprot;acc:q99798]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
200.342\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.959\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PMPCB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial processing peptidase beta subunit, mitochondrial precursor (ec 3.4.24.64) (beta-mpp) (p-52). [source:swissprot;acc:o75439]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.635\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
212.575\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0238\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1300\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.276\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.918\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02236\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PMPCA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial processing peptidase alpha subunit, mitochondrial precursor (ec 3.4.24.64) (alpha-mpp) (p-55) (ha1523). [source:swissprot;acc:q10713]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
212.576\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/